SCHEMBL22995156

SCHEMBL22995156

Cn1ncc2ccc(CO)cc2c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNC P24863 3/20 0.42
CDK8 P49336 3/20 0.42
PGR P06401 1/20 0.40
ERCC1 P07992 1/20 0.40
ERCC4 Q92889 1/20 0.40
ALDH1A2 O94788 2/20 0.39
ALDH1A1 P00352 2/20 0.39
ALDH1A3 P47895 2/20 0.39
PLAU P00749 1/20 0.38
NOTUM Q6P988 1/20 0.38
CA12 O43570 1/20 0.37
CA2 P00918 1/20 0.37
CA3 P07451 1/20 0.37
CA4 P22748 1/20 0.37
CA6 P23280 1/20 0.37
CA5A P35218 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
CA5B Q9Y2D0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29380296 0.79 HTR2A (0.41) ERCC1ERCC4ALDH1A2ALDH1A1ALDH1A3
SCHEMBL30903411 0.78 NOTUM (0.52) CCNCCDK8ERCC1ERCC4NOTUM
SCHEMBL14800197 0.78 NOTUM (0.52) CCNCCDK8ERCC1ERCC4NOTUM
SCHEMBL1375296 0.77 BRD4 (0.41) ALDH1A1HSD17B10BRD4BRD9KAT2B
SCHEMBL14966237 0.77 BPTF (0.44) ALDH1A1CA12CA9HSD17B10BRD4
SCHEMBL29702303 0.77 BRD4 (0.41) ALDH1A1HSD17B10BRD4BRD9KAT2B
SCHEMBL29702195 0.76 BPTF (0.43) ALDH1A2ALDH1A1ALDH1A3BRD4HTR2A
SCHEMBL1665815 0.73 CTNNB1 (0.54) CCNCCDK8NOTUMHTR2APASK
SCHEMBL29491495 0.73 CTNNB1 (0.54) CCNCCDK8NOTUMHTR2APASK
SCHEMBL22971729 0.73 ALDH1A1 (0.39) ALDH1A2ALDH1A1ALDH1A3KAT2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021028806-A1 HETEROCYCLIC WDR5 INHIBITORS AS ANTI-CANCER COMPOUNDS NOVARTIS AG (CH) 2021-02-18 WO disclosed